To include your compound in the COVID-19 Resource Center, submit it here.

GENZ lowers guidance again

Genzyme (GENZ) lowered its third quarter and 2002 full year EPS guidance to $0.26-$0.28 from $0.31-$0.33, and to $1.08-$1.11 from

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE